Alemtuzumab: validation of a sensitive and simple enzyme-linked immunosorbent assay

« Previous Next »Leukemia Research
Volume 28, Issue 12 , Pages 1255-1262, December 2004

Iman Jilani
- Department of Hematopathology, Nichols Institute, Quest Diagnostics, 33608 Ortega Highway, Rm#108B, San Juan Capistrano, CA 92690-6130, USA
Michael Keating
- Department of Leukemia, MD Anderson Cancer Center, University of Texas, Houston, TX, USA
Francis J. Giles
- Department of Leukemia, MD Anderson Cancer Center, University of Texas, Houston, TX, USA
Susan O’Brien
- Department of Leukemia, MD Anderson Cancer Center, University of Texas, Houston, TX, USA
Hagop M. Kantarjian
- Department of Leukemia, MD Anderson Cancer Center, University of Texas, Houston, TX, USA
Maher Albitar
- Department of Hematopathology, Nichols Institute, Quest Diagnostics, 33608 Ortega Highway, Rm#108B, San Juan Capistrano, CA 92690-6130, USA
- Corresponding author. Tel.: +1 949 728 4784; fax: +1 949 728 4990; (mobile: +1 949 275 7564).